Back
GraniteShares 2x Long NVDA Daily ETF Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
78
NVDL
GraniteShares 2x Long NVDA Daily ETF
Last Price:
83.22
Seasonality Move:
78.72%
Buy
100
RYTM
Rhythm Pharmaceuticals
Last Price:
67.31
Seasonality Move:
9.98%
Buy
78
GraniteShares 2x Long NVDA Daily ETF (NVDL)
is a Buy
Is GraniteShares 2x Long NVDA Daily ETF a Buy, Sell or Hold?
- The current GraniteShares 2x Long NVDA Daily ETF [NVDL] share price is $83.19. The Score for NVDL is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- NVDL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
100
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $67.33. The Score for RYTM is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
NVDL Stock Price Chart
What is GraniteShares 2x Long NVDA Daily ETF's stock price today?
-
The GraniteShares 2x Long NVDA Daily ETF share price today is $83.19
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVDL is experiencing slight selling pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $67.33
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVDL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.04 | Buy |
| Relative Strength Index (14 RSI): | 64.13 | Buy |
| Chaikin Money Flow: | -3322623 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.14 - 79.18) | Buy |
| Bollinger Bands (100): | (53.13 - 74.63) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.14 | Buy |
| Relative Strength Index (14 RSI): | 81.29 | Buy |
| Chaikin Money Flow: | 966983 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.36 - 56.78) | Buy |
| Bollinger Bands (100): | (43.87 - 52.87) | Buy |
NVDL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 76.01 | Buy |
| 20-day SMA: | 75.5 | Buy |
| 50-day SMA: | 64.03 | Buy |
| 200-day SMA: | 52.65 | Buy |
| 8-day EMA: | 78.46 | Buy |
| 20-day EMA: | 74.62 | Buy |
| 50-day EMA: | 68.42 | Buy |
| 200-day EMA: | 53.04 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.18 | Buy |
| 20-day SMA: | 52.43 | Buy |
| 50-day SMA: | 50.91 | Buy |
| 200-day SMA: | 45.07 | Buy |
| 8-day EMA: | 58.59 | Buy |
| 20-day EMA: | 54.14 | Buy |
| 50-day EMA: | 51.2 | Buy |
| 200-day EMA: | 44.61 | Buy |
GraniteShares 2x Long NVDA Daily ETF Earnings Growth & NVDL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.66 per share.
GraniteShares 2x Long NVDA Daily ETF Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||